Waldhäusl W - Search Results

1

Increased plasma levels of plasminogen activator inhibitor-1 and soluble vascular cell adhesion molecule after triacylglycerol infusion in man.

Krebs M, Geiger M, Polak K, Vales A, Schmetterer L, Wagner OF, Waldhäusl W, Binder BR, Roden M. Krebs M, et al. Among authors: waldhausl w. Thromb Haemost. 2003 Sep;90(3):422-8. doi: 10.1160/TH03-07-0457. Thromb Haemost. 2003. PMID: 12958610 Clinical Trial.

2

Reduction of plasma leptin concentrations by arginine but not lipid infusion in humans.

Stingl H, Raffesberg W, Nowotny P, Waldhäusl W, Roden M. Stingl H, et al. Among authors: waldhausl w. Obes Res. 2002 Nov;10(11):1111-9. doi: 10.1038/oby.2002.151. Obes Res. 2002. PMID: 12429874 Free article.

3

Mechanism of amino acid-induced skeletal muscle insulin resistance in humans.

Krebs M, Krssak M, Bernroider E, Anderwald C, Brehm A, Meyerspeer M, Nowotny P, Roth E, Waldhäusl W, Roden M. Krebs M, et al. Among authors: waldhausl w. Diabetes. 2002 Mar;51(3):599-605. doi: 10.2337/diabetes.51.3.599. Diabetes. 2002. PMID: 11872656 Clinical Trial.

4

Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients.

Anderwald C, Brabant G, Bernroider E, Horn R, Brehm A, Waldhäusl W, Roden M. Anderwald C, et al. Among authors: waldhausl w. Diabetes. 2003 Jul;52(7):1792-8. doi: 10.2337/diabetes.52.7.1792. Diabetes. 2003. PMID: 12829648

5

Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells.

Artwohl M, Roden M, Waldhäusl W, Freudenthaler A, Baumgartner-Parzer SM. Artwohl M, et al. Among authors: waldhausl w. FASEB J. 2004 Jan;18(1):146-8. doi: 10.1096/fj.03-0301fje. Epub 2003 Nov 3. FASEB J. 2004. PMID: 14597560

6

Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability.

Tremblay F, Krebs M, Dombrowski L, Brehm A, Bernroider E, Roth E, Nowotny P, Waldhäusl W, Marette A, Roden M. Tremblay F, et al. Among authors: waldhausl w. Diabetes. 2005 Sep;54(9):2674-84. doi: 10.2337/diabetes.54.9.2674. Diabetes. 2005. PMID: 16123357

7

Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycemia.

Bischof MG, Bernroider E, Krssak M, Krebs M, Stingl H, Nowotny P, Yu C, Shulman GI, Waldhäusl W, Roden M. Bischof MG, et al. Among authors: waldhausl w. Diabetes. 2002 Jan;51(1):49-54. doi: 10.2337/diabetes.51.1.49. Diabetes. 2002. PMID: 11756322

8

Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle.

Anderwald C, Bernroider E, Krssak M, Stingl H, Brehm A, Bischof MG, Nowotny P, Roden M, Waldhäusl W. Anderwald C, et al. Among authors: waldhausl w. Diabetes. 2002 Oct;51(10):3025-32. doi: 10.2337/diabetes.51.10.3025. Diabetes. 2002. PMID: 12351443 Clinical Trial.

9

Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes.

Kautzky-Willer A, Krssak M, Winzer C, Pacini G, Tura A, Farhan S, Wagner O, Brabant G, Horn R, Stingl H, Schneider B, Waldhäusl W, Roden M. Kautzky-Willer A, et al. Among authors: waldhausl w. Diabetes. 2003 Feb;52(2):244-51. doi: 10.2337/diabetes.52.2.244. Diabetes. 2003. PMID: 12540593

10

Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle.

Brehm A, Krssak M, Schmid AI, Nowotny P, Waldhäusl W, Roden M. Brehm A, et al. Among authors: waldhausl w. Diabetes. 2006 Jan;55(1):136-40. Diabetes. 2006. PMID: 16380486 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

464 results

Search Page

Filters